PARACENTRAL ACUTE MIDDLE MACULOPATHY AND OCULAR ISCHEMIC SYNDROME AFTER INTRANASAL STEROID INJECTION: A CASE REPORT

Jessica E Weinstein1, Margaret A Greven2

  • 1Department of Ophthalmology and Visual Sciences, University of Kentucky, Lexington, Kentucky; and.

Abstract

Insights

Intranasal steroid injections can cause vision loss, including paracentral acute middle maculopathy and ocular ischemic syndrome. Awareness is crucial for physicians to prevent potential adverse outcomes in patients.

Area of Science:

  • Ophthalmology
  • Endocrinology

Background:

  • Intranasal steroid injections are commonly used for various nasopharyngeal conditions.
  • Potential adverse effects, particularly ocular complications, require thorough investigation.

Approach:

  • This study presents a case report detailing a patient's experience following an intranasal steroid injection.
  • Diagnostic methods included optical coherence tomography and fluorescein angiography.

Key Points:

  • The patient developed transient amaurosis fugax and a persistent central scotoma in the right eye.
  • Optical coherence tomography revealed paracentral acute middle maculopathy.
  • Fluorescein angiography indicated diffuse ischemia with peripheral vessel staining and leakage.

Conclusions:

  • Intranasal steroid injections may precipitate retinal ischemic and vaso-occlusive events.
  • Ophthalmologists and other clinicians must be aware of this potential risk associated with facial and nasopharyngeal steroid injections.